Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,461 | -24,728 | -16,723 | -8,790 | -4,970 |
| Depreciation Amortization | 29 | 147 | 118 | 88 | 46 |
| Other Working Capital | -2,398 | 2,437 | 1,105 | -1,795 | -774 |
| Other Operating Activity | -56 | 2,260 | 2,020 | 1,933 | 1,362 |
| Operating Cash Flow | $-7,886 | $-19,884 | $-13,480 | $-8,564 | $-4,336 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 57,753 | 57,753 | 57,997 | 3,057 |
| Other Financing Activity | 0 | -186 | -177 | 0 | 0 |
| Financing Cash Flow | $N/A | $57,567 | $57,576 | $57,997 | $3,057 |
| Beginning Cash Position | 47,960 | 10,277 | 10,277 | 10,277 | 10,277 |
| End Cash Position | 40,074 | 47,960 | 54,373 | 59,710 | 8,998 |
| Net Cash Flow | $-7,886 | $37,683 | $44,096 | $49,433 | $-1,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,886 | -19,884 | -13,480 | -8,564 | -4,336 |
| Free Cash Flow | -7,886 | -19,884 | -13,480 | -8,564 | -4,336 |